Effective January 13, 2017, Andrew B. Cohen resigned as director of Kadmon Holdings Inc. Mr. Cohens resignation from the company's Board of Directors did not result from any disagreement with the company on any matters relating to the company's operations, policies or practices. On January 17, 2017, Steven Meehan was appointed to the company's Board, effective immediately. Mr. Meehan brings to the Board over 25 years of investment banking experience. He was formerly a Partner in the Healthcare Group of Moelis & Company leading the effort in Life Sciences and Advanced Diagnostics. Additionally, he was previously the Head of Life Sciences within the Global Healthcare Group in the New York office of UBS Investment Bank (UBS). Mr. Meehan was also part of the team that formed the Healthcare Group at UBS in 1999. During his tenure at UBS, he was Chief Executive Officer of UBS Russia and CIS across all businesses including securities, banking and wealth management. Mr. Meehan will serve as a member of the Board's Audit Committee.